HNF1A mutation in a Thai patient with maturity-onset diabetes of the young: A case report
- PMID: 31363388
- PMCID: PMC6656704
- DOI: 10.4239/wjd.v10.i7.414
HNF1A mutation in a Thai patient with maturity-onset diabetes of the young: A case report
Abstract
Background: Maturity-onset diabetes of the young (MODY) is the most common form of monogenic diabetes. The disease is transmitted in autosomal dominant mode and diabetes is usually diagnosed before age 25 year. MODY 3 is caused by mutation of hepatocyte nuclear factor (HNF) 1A genes and is the most common MODY subtype. Diagnosis of MODY 3 is crucial since glycemic control can be accomplished by very low dose of sulfonylurea. In this report we described a Thai MODY 3 patient who had excellence plasma glucose control by treating with glicazide 20 mg per day and insulin therapy can be discontinued.
Case summary: A 31-year-old woman was diagnosed diabetes mellitus at 14 years old. The disease was transmitted from her grandmother and mother compatible with autosomal dominant inheritance. Sanger sequencing of proband's DNA identified mutation of HNF1A at codon 203 which changed amino acid from arginine to cysteine (R203C). This mutation was carried only by family members who have diabetes. The patient has been treated effectively with a combination of oral hypoglycemic agents and must include a very low dose of glicazide (20 mg/d). Insulin therapy was successfully discontinued.
Conclusion: We demonstrated a first case of pharmacogenetics in Thai MODY 3 patient. Our findings underscore the essential role of molecular genetics in diagnosis and guidance of appropriate treatment of diabetes mellitus in particular patient.
Keywords: Case report; HNF1A; Maturity-onset diabetes of the young; Oral sulfonylureas.
Conflict of interest statement
Conflict-of-interest statement: The authors have no conflicts of interest to declare.
Figures



Similar articles
-
Treatment switch from multiple daily insulin injections to sulphonylureas in an African young adult diagnosed with HNF1A MODY: a case report.J Med Case Rep. 2024 Oct 17;18(1):506. doi: 10.1186/s13256-024-04850-3. J Med Case Rep. 2024. PMID: 39420387 Free PMC article.
-
Diagnosis of hepatic nuclear factor 1A monogenic diabetes mellitus (HNF1A-MODY) impacts antihyperglycemic treatment.Wien Klin Wochenschr. 2021 Mar;133(5-6):241-244. doi: 10.1007/s00508-020-01770-2. Epub 2020 Nov 27. Wien Klin Wochenschr. 2021. PMID: 33245425
-
Meglitinide analogues in adolescent patients with HNF1A-MODY (MODY 3).Pediatrics. 2014 Mar;133(3):e775-9. doi: 10.1542/peds.2012-2537. Epub 2014 Feb 24. Pediatrics. 2014. PMID: 24567025
-
Maturity-onset diabetes of the young (MODY): an update.J Pediatr Endocrinol Metab. 2015 Mar;28(3-4):251-63. doi: 10.1515/jpem-2014-0384. J Pediatr Endocrinol Metab. 2015. PMID: 25581748 Review.
-
Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a(-/-) Model.Curr Pharm Des. 2015;21(39):5736-48. doi: 10.2174/1381612821666151008124036. Curr Pharm Des. 2015. PMID: 26446475 Review.
Cited by
-
HNF1A POU Domain Mutations Found in Japanese Liver Cancer Patients Cause Downregulation of HNF4A Promoter Activity with Possible Disruption in Transcription Networks.Genes (Basel). 2022 Feb 24;13(3):413. doi: 10.3390/genes13030413. Genes (Basel). 2022. PMID: 35327967 Free PMC article.
-
Incidence and prevalence of type 1 diabetes and diabetic ketoacidosis in children and adolescents (0-19 years) in Thailand (2015-2020): A nationwide population-based study.Lancet Reg Health West Pac. 2022 Feb 3;21:100392. doi: 10.1016/j.lanwpc.2022.100392. eCollection 2022 Apr. Lancet Reg Health West Pac. 2022. PMID: 35169761 Free PMC article.
-
Novel HNF1A gene mutation in maturity-onset diabetes of the young: A case report.World J Clin Cases. 2022 Feb 26;10(6):1909-1913. doi: 10.12998/wjcc.v10.i6.1909. World J Clin Cases. 2022. PMID: 35317157 Free PMC article.
-
Investigation of Monogenic Diabetes Genes in Thai Children with Autoantibody Negative Diabetes Requiring Insulin.Diabetes Metab Syndr Obes. 2024 Feb 14;17:795-808. doi: 10.2147/DMSO.S409713. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38375489 Free PMC article.
-
Treatment switch from multiple daily insulin injections to sulphonylureas in an African young adult diagnosed with HNF1A MODY: a case report.J Med Case Rep. 2024 Oct 17;18(1):506. doi: 10.1186/s13256-024-04850-3. J Med Case Rep. 2024. PMID: 39420387 Free PMC article.
References
-
- Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med. 2001;345:971–980. - PubMed
-
- Siddiqui K, Musambil M, Nazir N. Maturity onset diabetes of the young (MODY)--history, first case reports and recent advances. Gene. 2015;555:66–71. - PubMed
-
- Tonooka N, Tomura H, Takahashi Y, Onigata K, Kikuchi N, Horikawa Y, Mori M, Takeda J. High frequency of mutations in the HNF-1alpha gene in non-obese patients with diabetes of youth in Japanese and identification of a case of digenic inheritance. Diabetologia. 2002;45:1709–1712. - PubMed
Publication types
LinkOut - more resources
Full Text Sources